Vitamin K antagonists or low-molecular weight heparin for venous thromboembolism
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Vitamin K Antagonists or Low-molecular Weight Heparin for Venous Thromboembolism." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/456257/all/Vitamin_K_antagonists_or_low_molecular_weight_heparin_for_venous_thromboembolism.
Vitamin K antagonists or low-molecular weight heparin for venous thromboembolism. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2024. https://evidence.unboundmedicine.com/evidence/view/EBMG/456257/all/Vitamin_K_antagonists_or_low_molecular_weight_heparin_for_venous_thromboembolism. Accessed November 12, 2024.
Vitamin K antagonists or low-molecular weight heparin for venous thromboembolism. (2024). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/456257/all/Vitamin_K_antagonists_or_low_molecular_weight_heparin_for_venous_thromboembolism
Vitamin K Antagonists or Low-molecular Weight Heparin for Venous Thromboembolism [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2024. [cited 2024 November 12]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/456257/all/Vitamin_K_antagonists_or_low_molecular_weight_heparin_for_venous_thromboembolism.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Vitamin K antagonists or low-molecular weight heparin for venous thromboembolism
ID - 456257
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/456257/all/Vitamin_K_antagonists_or_low_molecular_weight_heparin_for_venous_thromboembolism
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -